1,5-benzothiazepines and their use as hypolipidaemics

Details for Australian Patent Application No. 2001237556 (hide)

Owner AstraZeneca AB

Inventors Starke, Ingemar; Blomberg, David; Dahlstrom, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2001237556

PCT Pub. Number WO01/66533

Priority 0000772-4 08.03.00 SE

Filing date 5 March 2001

Wipo publication date 17 September 2001

Acceptance publication date 7 October 2004

International Classifications

C07D 281/10 Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 031/554 - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

C07F 009/6536 Compounds containing elements of the 5th Group of the Periodic System

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 003/06 Drugs for disorders of the metabolism

A61K 031/662 - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

Event Publications

7 October 2004 Application Accepted

  Published as AU-B-2001237556

3 February 2005 Standard Patent Sealed

12 October 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001237557

2001237555